相关实验视频

Updated: Sep 17, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

不故意检测出白血病与完整的血清

Yung Gonzaga¹, Felipe Nogueira Barbara², Luis C L Correia²

¹From the Department of Hematology, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil (YG); Grupo Oncoclínicas, Rio de Janeiro, Brazil (YG); Independent Researcher (FNB); Rollins School of Public Health, Emory University, Atlanta, GA (LCLC); Escola Bahiana de Medicina e Saúde Pública, Salvador, Bahia, Brazil (LCLC); Clinical Research and Technological Development Divison, Research and Innovation Coordination, Instituto Nacional de Câncer (INCA), Ministry of Health, Rio de Janeiro, Brazil (AM); Professional Master's Program in Health Technology Assessment, Teaching and Research Coordination, Instituto Nacional de Cardiologia (INC), Rio de Janeiro, Brazil (AM). ygonzaga@inca.gov.br).

Journal of the American Board of Family Medicine : JABFM

|June 27, 2025

概括

完整血清 (CBC) 可以无意中检测无症状患者的白血病. 通过CBC早期检测可能会改善结果,但临床医生必须权衡好处与危害和局限性.

科学领域:

血液学血液学血液学
在瘤学瘤学.
诊断医学诊断医学

背景情况:

全血细胞计 (CBC) 是一种全球普遍的诊断测试.
CBC量化了血液细胞,提供了有关骨髓功能的见解,这是大多数白血病的起源.
白血病可能通过常规CBC检测偶然检测出来.

研究的目的:

探索通过CBC在无症状个体中偶发性白血病检测的影响.
作为一个教学工具,以了解偶然发现的好处,危害和局限性.
为初级保健临床医生提供有关管理偶然疾病检测的信息.

主要方法:

审查CBC在评估骨髓功能和检测血液学异常方面的作用.
讨论查原则及其对偶然发现的适用性.
分析偶然检测的潜在益处 (早期治疗) 和危害 (过度诊断,焦虑).

主要成果:

CBC在没有先前症状的个体中识别白血病的潜力.
偶然检测与白血病正式查的概念.
考虑早期诊断和潜在的不良影响之间的平衡.

结论:

偶然的CBC发现可能导致早期白血病诊断,可能改善患者的治疗结果.
初级保健医生必须仔细考虑与偶然疾病检测相关的益处,危害和限制.
需要进一步讨论如何在无症状人群中管理偶然发现.

关键词:

癌症癌症癌症癌症完整的血液计数完整的血液计数诊断测试诊断测试诊断测试血液学血液学血液学偶然发现偶然发现在白血病中,白血病.过度治疗过度治疗初级医疗保健是一项主要的医疗保健服务.查检查查检查查检查

更多相关视频

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

相关概念视频

Disorders of Leukocytes

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...